be_ixf;ym_202512 d_08; ct_50
NYSE:GENI charts & data provided by TradingView

Latest Insights on GENI

Molecules of U.S. Freedom May 30, 2019 by Joseph Hargett Great Stuff I’m sorry … I just can’t stop laughing… “Freedom gas”!  OK, breathe… This week … ahem … the Department of Energy (DOE), in all seriousness, rebranded natural gas with a more patriotic spin. In most aspects, it was your standard report on the health of the U.S. natural gas market. The government agency touted the development of […]
Great Stuff 5-24-2019 T-Mobile Pulls a Fast One; Amazon at $3,000? May 24, 2019 by Joseph Hargett Great Stuff The Friday Four Play No. 1: T-Mobile + Netflix On You While the Federal Communications Commission and the Department of Justice are battling it out over whether T-Mobile USA Inc. (Nasdaq: TMUS) and Sprint Corp. (NYSE: S) should be allowed to get married, the “Big T” is pulling a fast one. T-Mobile’s Netflix On Us […]
ALERT: Top Investor Reveals Safe Pot Stock Trades May 16, 2019 by Charles Mizrahi American Investor Today, Cannabis, Investing Whenever a new trend starts in the market, many companies rival to be the top dog. Once the craze dies down, however, only a few companies capture all of the available market share for that industry. To make money from a trend, it’s crucial to know how to pick profitable companies. Charles Mizrahi shares with you an exclusive presentation on a booming mega trend: the cannabis market. (3-minute read)
Why Choosing Stock Market Winners Makes You a Better Trader April 18, 2019 by Charles Mizrahi American Investor Today, Investing The best way to be a winner is to surround yourself with winners. Charles Mizrahi shares his take on this well-known motto with you, and how he applies it to his expertise when it comes to choosing stocks that are set to make huge gains.
The amount of new clinical trials is increasing exponentially. This gives constant opportunities to profit from biotech companies releasing results. Biotech Has More Opportunities Than Ever Before September 19, 2018 by Ian Dyer Investment Opportunities The amount of new clinical trials is increasing exponentially. This gives constant opportunities to profit from biotech companies releasing results.

Newsletter Sign Up

Sponsored

CS Care Video

MEET OUR EXPERTS

WHAT READERS ARE SAYING..

"You told me to ignore the noise on Wall Street. And thanks to you, I started towards the end of 2016 with $200,000 in my account and I recently put in an extra $100,000. [As of February 2019] My account is worth $500,788! I would’ve missed out if I followed conventional wisdom."

- Helen C.

“Looks like I have finally found the right person to learn and grow from.”

- James

“My portfolio has grown from 275k to almost 900k with only investments made with Banyan Hill.”

- David G. (Member since 2018)

Share This